Research and Markets: Tarceva (Non-Small Cell Lung Cancer) – Forecast and … – The Herald | HeraldOnline.com

by lowes1 on September 19, 2013

Research and Markets: Tarceva (Non-Small Cell Lung Cancer) – Forecast and
The Herald | HeraldOnline.com
Non-Small Cell Lung Cancer (NSCLC) is the most common lung cancer, and the second-most common cancer in men and women. Historically, the treatment paradigm has centered around chemotherapy. However, the launch of targeted therapies for patients 

View full post on lung cancer – Google News

Leave a Comment

Previous post:

Next post: